NYSE · ANVSHealthcarePharmaceuticals

Annovis Bio news

$1.30−5.80%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0

About Annovis Bio

No recent articles focused on Annovis Bio.

Also mentions ANVS

Articles that tag ANVS but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology